Financhill
Back

GT Biopharma Quote, Financials, Valuation and Earnings

GT Biopharma Price Quote

$3.30

GT Biopharma Key Stats

Sell
17
GT Biopharma (GTBP) is a Sell

Day range:
$3.30 - $3.50
52-week range:
$2.95 - $16.11
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
71.30
P/B ratio:
0.61%

Volume:
2.9K
Avg. volume:
11.7K
1-year change:
-63.09%
Market cap:
$4.6M
Revenue:
$0
EPS:
$-5.58

How Much Does GT Biopharma Make?

Data Unavailable

Is GT Biopharma Growing As A Company?

Data Unavailable

GT Biopharma Stock Price Performance

  • Did GT Biopharma Stock Go Up Last Month?
    GT Biopharma share price went down by -29.03% last month
  • Did GTBP's Share Price Rise Over The Last Year?
    GTBP share price fell by -63.09% over the past 1 year

What Is GT Biopharma 52-Week High & Low?

GT Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy GT Biopharma?

  • How Much Debt Does GT Biopharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does GT Biopharma Have?
    Cash and short term investments quarterly total is $14M
  • What Is GT Biopharma’s Book Value Per Share?
    Book value per share is 5.41

Is GT Biopharma Cash Flow Positive?

  • What Is GTBP Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is GT Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $6.3M
  • What Is GT Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2M

GT Biopharma Return On Invested Capital

Data Unavailable

GT Biopharma Earnings Date & Stock Price

  • What Is GT Biopharma's Stock Price Today?
    A single share of GTBP can be purchased today for 3.30
  • What Is GT Biopharma’s Stock Symbol?
    GT Biopharma trades on the nasdaq under the ticker symbol: GTBP
  • When Is GT Biopharma’s Next Earnings Date?
    The next quarterly earnings date for GT Biopharma is scheduled on May 15, 2024
  • When Is GTBP's next ex-dividend date?
    GT Biopharma's next ex-dividend date is May 4, 2024
  • How To Buy GT Biopharma Stock?
    You can buy GT Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

GT Biopharma Competitors

  • Who Are GT Biopharma's Competitors?
    Below is a list of companies who compete with GT Biopharma or are related in some way:
    • 180 Life Sciences Corp (ATNF)
    • Cutera Inc (CUTR)
    • Journey Medical Corp (DERM)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Outlook Therapeutics Inc (OTLK)

GT Biopharma Dividend Yield

Data Unavailable

GT Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 150.00
Upside from Last Price: 4445.46%

Major Shareholders

  • How many GTBP shares are owned by institutional investors?
    224.4K GTBP shares are owned by institutional investors
  • How many GTBP shares are owned by insiders?
    14M GTBP shares are owned by insiders